What information must be disclosed regarding alcohol and substance abuse?

The correct choice emphasizes the need for patient confidentiality and autonomy in the context of alcohol and substance abuse treatment. Federal regulations, notably 42 CFR Part 2, protect the privacy of individuals receiving treatment for substance use disorders. This legal framework requires explicit consent from the patient before any of their information regarding substance abuse can be disclosed to third parties, including healthcare providers and family members.

The requirement for patient permission is essential to maintain trust in the therapeutic relationship, encouraging individuals to seek help without the fear of unwanted disclosure of their sensitive health information. The regulations are designed to reduce stigma and ensure that patients feel secure in sharing vital health information with their treatment providers. Understanding this aspect is crucial for maintaining compliance with healthcare regulations and protecting patient rights.